176 related articles for article (PubMed ID: 17073887)
1. Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant.
Bas M; Bier H; Greve J; Kojda G; Hoffmann TK
Allergy; 2006 Dec; 61(12):1490-2. PubMed ID: 17073887
[No Abstract] [Full Text] [Related]
2. Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant).
Bork K; Frank J; Grundt B; Schlattmann P; Nussberger J; Kreuz W
J Allergy Clin Immunol; 2007 Jun; 119(6):1497-503. PubMed ID: 17418383
[TBL] [Abstract][Full Text] [Related]
3. Treatment of idiopathic nonhistaminergic angioedema with bradykinin B2 receptor antagonist icatibant.
Del Corso I; Puxeddu I; Sardano E; Geraci S; Breggia M; Rocchi V; Migliorini P
Ann Allergy Asthma Immunol; 2012 Jun; 108(6):460-1. PubMed ID: 22626601
[No Abstract] [Full Text] [Related]
4. Icatibant , the bradykinin B2 receptor antagonist with target to the interconnected kinin systems.
Charignon D; Späth P; Martin L; Drouet C
Expert Opin Pharmacother; 2012 Oct; 13(15):2233-47. PubMed ID: 22970904
[TBL] [Abstract][Full Text] [Related]
5. Successful long-term treatment with the bradykinin B2 receptor antagonist icatibant in a patient with hereditary angioedema.
Greve J; Hoffmann TK; Schuler P; Lang S; Chaker A; Bas M
Int J Dermatol; 2011 Oct; 50(10):1294-5. PubMed ID: 21950301
[TBL] [Abstract][Full Text] [Related]
6. Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial.
Lumry WR; Li HH; Levy RJ; Potter PC; Farkas H; Moldovan D; Riedl M; Li H; Craig T; Bloom BJ; Reshef A
Ann Allergy Asthma Immunol; 2011 Dec; 107(6):529-37. PubMed ID: 22123383
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of hereditary angioedema with bradykinin B2-receptor antagonist icatibant.
Krause K; Metz M; Zuberbier T; Maurer M; Magerl M
J Dtsch Dermatol Ges; 2010 Apr; 8(4):272-4. PubMed ID: 19758369
[TBL] [Abstract][Full Text] [Related]
8. Treatment of angiotensin-converting enzyme inhibitor-related angioedema with the bradykinin B2 receptor antagonist icatibant.
Schmidt PW; Hirschl MM; Trautinger F
J Am Acad Dermatol; 2010 Nov; 63(5):913-4. PubMed ID: 20554347
[No Abstract] [Full Text] [Related]
9. Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series.
Bas M; Greve J; Stelter K; Bier H; Stark T; Hoffmann TK; Kojda G
Ann Emerg Med; 2010 Sep; 56(3):278-82. PubMed ID: 20447725
[TBL] [Abstract][Full Text] [Related]
10. Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study.
Zanichelli A; Bova M; Coerezza A; Petraroli A; Triggiani M; Cicardi M
Allergy; 2012 Aug; 67(8):1074-7. PubMed ID: 22686628
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of an acute attack of acquired angioedema with the bradykinin-B2-receptor antagonist icatibant.
Weller K; Magerl M; Maurer M
J Eur Acad Dermatol Venereol; 2011 Jan; 25(1):119-20. PubMed ID: 20477917
[No Abstract] [Full Text] [Related]
12. Icatibant: a novel approach to the treatment of angioedema related to the use of angiotensin-converting enzyme inhibitors.
Gallitelli M; Alzetta M
Am J Emerg Med; 2012 Oct; 30(8):1664.e1-2. PubMed ID: 22100478
[TBL] [Abstract][Full Text] [Related]
13. Bradykinin receptor antagonists--a review of the patent literature 2005-2008.
Fincham CI; Bressan A; Paris M; Rossi C; Fattori D
Expert Opin Ther Pat; 2009 Jul; 19(7):919-41. PubMed ID: 19552510
[TBL] [Abstract][Full Text] [Related]
14. In brief: icatibant (Firazyr) for hereditary angioedema.
Medical Letter
Med Lett Drugs Ther; 2011 Nov; 53(1378):96. PubMed ID: 22113125
[No Abstract] [Full Text] [Related]
15. Peptide and non-peptide bradykinin receptor antagonists: role in allergic airway disease.
Abraham WM; Scuri M; Farmer SG
Eur J Pharmacol; 2006 Mar; 533(1-3):215-21. PubMed ID: 16455073
[TBL] [Abstract][Full Text] [Related]
16. [Icatibant is a new treatment option in life-threatening angioedema triggered by angiotensin-converting enzyme inhibitor].
Fast S; Henningsen E; Bygum A
Ugeskr Laeger; 2011 Oct; 173(41):2574-5. PubMed ID: 21985837
[TBL] [Abstract][Full Text] [Related]
17. [Emergency management of acute angioedema].
Bas M; Greve J; Bier H; Knopf A; Stark T; Schuler P; Hoffmann TK; Kojda G
Dtsch Med Wochenschr; 2010 May; 135(20):1027-31. PubMed ID: 20461661
[TBL] [Abstract][Full Text] [Related]
18. Home treatment of hereditary angioedema with icatibant administered by health care professionals.
Farkas H; Csuka D; Zotter Z; Varga L; Böröcz Z; Temesszentandrási G; Jakab L; Karádi I
J Allergy Clin Immunol; 2012 Mar; 129(3):851-852.e2. PubMed ID: 22154383
[No Abstract] [Full Text] [Related]
19. Aspirin inhibits human bradykinin B2 receptor ligand binding function.
Gardes J; Michineau S; Pizard A; Alhenc-Gelas F; Rajerison RM
Biochem Pharmacol; 2008 May; 75(9):1807-16. PubMed ID: 18355801
[TBL] [Abstract][Full Text] [Related]
20. Treatment with icatibant in the management of drug induced angioedema.
Bertazzoni G; Bresciani E; Cipollone L; Fante E; Galandrini R
Eur Rev Med Pharmacol Sci; 2015 Jan; 19(1):149-53. PubMed ID: 25635988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
